ArticleRMD open2024

Fibroblast-like synoviocyte targeting antibodies are associated with failure to reach early and sustained remission or low disease activity after first-line therapy in rheumatoid arthritis.

Patrick Vandormael et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.